What Insmed Incorporated's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 5 | 169 |
| Total trades | 12 | 249 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 279,301 | 1,019,665 |
| Disposed | 297,023 | 1,217,708 |
| Net activity | −17,722 | −198,043 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Koppikar Utpal | Director | Oct 19 | Grant / award · A | +6,139 | — | — | 6,139 |
| Hudson Paul | Director | Oct 19 | Grant / award · A | +6,139 | — | — | 6,139 |
| Brennan David R | Director | Sep 09 | Open-market sale · S | −25,000 | $124.00 | −$3.1M | 39,238 |
| Sharoky Melvin Md | Director | Aug 17 | Open-market sale · S | −5,000 | $127.53 | −$638K | 0 |
| Adsett Roger | Chief Operating Officer | Aug 10 | Open-market sale · S | −239,850 | $133.27 | −$32M | 98,744 |
| Adsett Roger | Chief Operating Officer | Aug 10 | Exercise / conversion · M | +80,970 | $30.46 | +$2.47M | 338,594 |
| Adsett Roger | Chief Operating Officer | Aug 10 | Exercise / conversion · M | +76,600 | $17.16 | +$1.31M | 257,624 |
| Adsett Roger | Chief Operating Officer | Aug 10 | Exercise / conversion · M | +82,280 | $13.67 | +$1.12M | 181,024 |
| Flammer Martina M.d. | Chief Medical Officer | Aug 06 | Open-market sale · S | −18,278 | $129.40 | −$2.37M | 60,486 |
| Flammer Martina M.d. | Chief Medical Officer | Aug 06 | Open-market sale · S | −8,895 | $127.00 | −$1.13M | 78,764 |
| Flammer Martina M.d. | Chief Medical Officer | Aug 06 | Exercise / conversion · M | +8,895 | $25.83 | +$230K | 87,659 |
| Flammer Martina M.d. | Chief Medical Officer | Aug 06 | Exercise / conversion · M | +18,278 | $18.95 | +$346K | 78,764 |
| Lewis William | Chair and CEO | Jul 23 | Open-market sale · S | −5,872 | $106.43 | −$625K | 259,058 |
| Lewis William | Chair and CEO | Jul 23 | Open-market sale · S | −4,828 | $105.62 | −$510K | 264,930 |
| Lewis William | Chair and CEO | Jul 23 | Exercise / conversion · M | +4,440 | $17.16 | +$76.2K | 269,758 |
| Lewis William | Chair and CEO | Jul 23 | Exercise / conversion · M | +6,260 | $30.46 | +$191K | 265,318 |
| Lewis William | Chair and CEO | Jul 09 | Open-market sale · S | −3,359 | $118.52 | −$398K | 259,058 |
| Lewis William | Chair and CEO | Jul 09 | Open-market sale · S | −2,335 | $117.62 | −$275K | 262,417 |
| Lewis William | Chair and CEO | Jul 09 | Open-market sale · S | −5,005 | $116.55 | −$583K | 264,752 |
| Lewis William | Chair and CEO | Jul 09 | Exercise / conversion · M | +4,440 | $17.16 | +$76.2K | 269,757 |
Loading...
